Alivus Life Sciences Limited (BOM:543322)
India
· Delayed Price · Currency is INR 1,008.60
-36.85 (-3.52%)
At close: Apr 28, 2026
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 123.68 billion as of April 28, 2026. Its market cap has increased by 0.82% in one year.
Market Cap
123.68B
Enterprise Value
117.75B
Revenue
25.12B
Ranking
n/a
PE Ratio
22.75
Stock Price
1,008.60
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 123.68B, an increase of 34.85%. That is a compound annual growth rate of 6.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 123.68B | 9.98% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 184.87B |
| Shilpa Medicare | 80.93B |
| Suven Life Sciences | 53.25B |
| Gujarat Themis Biosyn | 39.25B |
| IOL Chemicals and Pharmaceuticals | 26.12B |
| Sai Parenteral's | 21.42B |
| NGL Fine-Chem | 13.80B |
| Bajaj HealthCare | 10.25B |